Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory

[1]  H. Nishijo,et al.  Phenolic compounds prevent beta-amyloid-protein oligomerization and synaptic dysfunction by site-specific binding , 2012, Alzheimer's & Dementia.

[2]  T. Bliss,et al.  Synaptic plasticity, memory and the hippocampus: a neural network approach to causality , 2012, Nature Reviews Neuroscience.

[3]  W. K. Cullen,et al.  Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory , 2012, Molecular Brain.

[4]  R. Malinow.  New developments on the role of NMDA receptors in Alzheimer's disease , 2012, Current Opinion in Neurobiology.

[5]  K. Reymann,et al.  N‐Terminal pyroglutamate formation of Aβ38 and Aβ40 enforces oligomer formation and potency to disrupt hippocampal long‐term potentiation , 2012, Journal of neurochemistry.

[6]  N. Kato,et al.  Intraneuronally injected amyloid β inhibits long-term potentiation in rat hippocampal slices. , 2012, Journal of neurophysiology.

[7]  K. Reymann,et al.  Structural basis of β-amyloid-dependent synaptic dysfunctions. , 2012, Angewandte Chemie.

[8]  G. Taglialatela,et al.  α‐Synuclein oligomers oppose long‐term potentiation and impair memory through a calcineurin‐dependent mechanism: relevance to human synucleopathic diseases , 2012, Journal of neurochemistry.

[9]  M. Rowan,et al.  Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances , 2012, Pharmacology Biochemistry and Behavior.

[10]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[11]  S. Lipton,et al.  Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-d-aspartate receptors , 2012, Proceedings of the National Academy of Sciences.

[12]  J. Collinge,et al.  PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis , 2012, Science.

[13]  L. Reijmers,et al.  Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice , 2012, PloS one.

[14]  J. Jhamandas,et al.  Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain , 2012, Expert Reviews in Molecular Medicine.

[15]  S. Lesné,et al.  Soluble Aβ oligomer production and toxicity , 2012, Journal of neurochemistry.

[16]  E. Klann,et al.  Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease , 2012, Journal of neurochemistry.

[17]  D. Holtzman,et al.  The biology of Alzheimer disease , 2012 .

[18]  W. Danysz,et al.  Behavioural and cellular effects of exogenous amyloid-β peptides in rodents , 2011, Behavioural Brain Research.

[19]  D. Selkoe,et al.  Aβ oligomers inhibit synapse remodelling necessary for memory consolidation , 2011, Neurobiology of Aging.

[20]  K. Ashe,et al.  Cognitive effects of cell-derived and synthetically derived Aβ oligomers , 2011, Neurobiology of Aging.

[21]  T. Härd.  Protein engineering to stabilize soluble amyloid β‐protein aggregates for structural and functional studies , 2011, The FEBS journal.

[22]  M. Rowan,et al.  A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ , 2011, Journal of neurochemistry.

[23]  T. Bayer,et al.  Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[24]  F. Jessen,et al.  Nitration of Tyrosine 10 Critically Enhances Amyloid β Aggregation and Plaque Formation , 2011, Neuron.

[25]  Alun Williams,et al.  Amyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins , 2011, The Journal of Biological Chemistry.

[26]  Hélène Marie,et al.  Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? , 2011, Alzheimer's & Dementia.

[27]  C. Broeckhoven,et al.  Potent amyloidogenicity and pathogenicity of Aβ43 , 2011, Nature Neuroscience.

[28]  L. Mucke,et al.  Ablation of Cellular Prion Protein Does Not Ameliorate Abnormal Neural Network Activity or Cognitive Dysfunction in the J20 Line of Human Amyloid Precursor Protein Transgenic Mice , 2011, The Journal of Neuroscience.

[29]  K. Blennow,et al.  Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid , 2011, Proceedings of the National Academy of Sciences.

[30]  U. Sengupta,et al.  Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice , 2011, Molecular Neurodegeneration.

[31]  A. Giese,et al.  AMPA‐receptor‐mediated excitatory synaptic transmission is enhanced by iron‐induced α‐synuclein oligomers , 2011, Journal of neurochemistry.

[32]  M. Hoch,et al.  Extracellular phosphorylation of the amyloid β‐peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease , 2011, The EMBO journal.

[33]  M. Rowan,et al.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites , 2011, Nature communications.

[34]  M. Rowan,et al.  Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein , 2011, The Journal of Neuroscience.

[35]  Shaomin Li,et al.  Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors , 2011, The Journal of Neuroscience.

[36]  A. Palmeri,et al.  Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory , 2011, Annals of neurology.

[37]  Julie Harris,et al.  Reversing EphB2 depletion rescues cognitive functions in Alzheimer model , 2011, Nature.

[38]  R. Panush.  Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis , 2011 .

[39]  Michael R. Schmidt,et al.  Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. , 2011, Nature chemical biology.

[40]  J. Marsh,et al.  Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers , 2010, Molecular Neurodegeneration.

[41]  S. Gentleman,et al.  α-synuclein induced synapse damage is enhanced by amyloid-β1-42 , 2010, Molecular Neurodegeneration.

[42]  Igor Tsigelny,et al.  Cell-to-cell transmission of non-prion protein aggregates , 2010, Nature Reviews Neurology.

[43]  Frank Baumann,et al.  Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis , 2010, Science.

[44]  N. Ferguson,et al.  Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils , 2010, The Journal of Neuroscience.

[45]  George Perry.  Faculty Opinions recommendation of The prion protein as a receptor for amyloid-beta. , 2010 .

[46]  S. Strittmatter,et al.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse , 2010, BMC Neuroscience.

[47]  Inna Kuperstein,et al.  Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio , 2010, The EMBO journal.

[48]  J. Witton,et al.  The functional neurophysiology of the amyloid precursor protein (APP) processing pathway , 2010, Neuropharmacology.

[49]  W. Klein,et al.  ADDLs and the signaling web that leads to Alzheimer’s disease , 2010, Neuropharmacology.

[50]  R. Malinow,et al.  The prion protein as a receptor for amyloid-β , 2010, Nature.

[51]  A. Aguzzi,et al.  Supplementary figure legends , 2010 .

[52]  G. Collingridge,et al.  Long-term depression in the CNS , 2010, Nature Reviews Neuroscience.

[53]  W. Surewicz,et al.  Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. , 2010, The Journal of biological chemistry.

[54]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[55]  M. Ntzouni,et al.  Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival , 2010, The Journal of Neuroscience.

[56]  P. Neudecker,et al.  Structural properties and dynamic behavior of nonfibrillar oligomers formed by PrP(106-126). , 2010, Journal of the American Chemical Society.

[57]  S. Strittmatter,et al.  Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein , 2010, The Journal of Neuroscience.

[58]  D. Selkoe,et al.  The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. , 2010, Brain : a journal of neurology.

[59]  K. Blennow,et al.  Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease , 2010, Acta Neuropathologica.

[60]  Alun Williams,et al.  Phospholipase A2 inhibitors protect against prion and Aβ mediated synapse degeneration , 2010, Molecular Neurodegeneration.

[61]  J. Moreno,et al.  Dysfunction and recovery of synapses in prion disease: implications for neurodegeneration. , 2010, Biochemical Society transactions.

[62]  Rodrigo Morales,et al.  Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases , 2010, The Journal of Neuroscience.

[63]  M. Diamond,et al.  Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.

[64]  G. D. Paolo,et al.  Faculty Opinions recommendation of Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. , 2010 .

[65]  G. Juhász,et al.  Controlled in situ preparation of Aβ(1–42) oligomers from the isopeptide “iso-Aβ(1–42)”, physicochemical and biological characterization , 2010, Peptides.

[66]  Joan-Emma Shea,et al.  Oligomers of the prion protein fragment 106-126 are likely assembled from beta-hairpins in solution, and methionine oxidation inhibits assembly without altering the peptide's monomeric conformation. , 2010, Journal of the American Chemical Society.

[67]  M. Gobbi,et al.  Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein , 2010, Proceedings of the National Academy of Sciences.

[68]  W. Banks,et al.  A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory , 2010 .

[69]  W. Banks,et al.  A physiological role for amyloid-beta protein:enhancement of learning and memory. , 2010, Journal of Alzheimer's disease : JAD.

[70]  N. Inestrosa,et al.  β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure* , 2009, The Journal of Biological Chemistry.

[71]  D. Selkoe,et al.  Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life , 2009, Neurobiology of Disease.

[72]  N. Hooper,et al.  Prion protein and Alzheimer disease , 2009, Prion.

[73]  M. Luca,et al.  Faculty Opinions recommendation of Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. , 2009 .

[74]  F. Nicoletti,et al.  β-Amyloid Monomers Are Neuroprotective , 2009, The Journal of Neuroscience.

[75]  V. Perry,et al.  Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology , 2009, Neurobiology of Disease.

[76]  Shaomin Li,et al.  Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.

[77]  Benjamin R. Rost,et al.  Role of Amyloid-β Glycine 33 in Oligomerization, Toxicity, and Neuronal Plasticity , 2009, The Journal of Neuroscience.

[78]  G. Zamponi.  Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[79]  R. Metherate,et al.  A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses , 2009, The Journal of Neuroscience.

[80]  C. Alberini,et al.  Amyloid beta mediates memory formation. , 2009, Learning & memory.

[81]  W. Klein,et al.  Targeting generation of antibodies specific to conformational epitopes of amyloid beta-derived neurotoxins. , 2009, CNS & neurological disorders drug targets.

[82]  N. Vassallo.  Properties and pathogenicity of prion-derived peptides. , 2009, Protein and peptide letters.

[83]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[84]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[85]  C. Glabe,et al.  Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.

[86]  D. Teplow,et al.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. , 2008, Current pharmaceutical design.

[87]  Hans-Ulrich Demuth,et al.  Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology , 2008, Nature Medicine.

[88]  B. Kriem,et al.  N-truncated amyloid-β oligomers induce learning impairment and neuronal apoptosis , 2008, Neurobiology of Aging.

[89]  M. Rowan,et al.  Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. , 2008, Brain : a journal of neurology.

[90]  S. Lehmann,et al.  Cellular pathogenesis in prion diseases. , 2008, Veterinary research.

[91]  Shaomin Li,et al.  Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation* , 2008, Journal of Biological Chemistry.

[92]  W. K. Cullen,et al.  Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization , 2008, The Journal of Neuroscience.

[93]  Yasuyoshi Watanabe,et al.  A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia , 2008, Annals of neurology.

[94]  A. Draguhn,et al.  Amyloid β Oligomers (Aβ1–42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents , 2008, The Journal of Neuroscience.

[95]  R. D'Hooge,et al.  Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice , 2007, The EMBO Journal.

[96]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[97]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[98]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[99]  C. Peers,et al.  Physiological roles for amyloid β peptides , 2006 .

[100]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[101]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[102]  C. Peers,et al.  Physiological roles for amyloid beta peptides. , 2006, The Journal of physiology.

[103]  C. Ross,et al.  What is the role of protein aggregation in neurodegeneration? , 2005, Nature Reviews Molecular Cell Biology.

[104]  W. K. Cullen,et al.  Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.

[105]  W. K. Cullen,et al.  Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.

[106]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[107]  C. Finch,et al.  Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.

[108]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[109]  W. K. Cullen,et al.  Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo , 2004, The European journal of neuroscience.

[110]  B. Volpe,et al.  Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo , 2004, Science.

[111]  C. Finch,et al.  Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[112]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[113]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[114]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[115]  R. Wetzel,et al.  Conformational Abs recognizing a generic amyloid fibril epitope , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[116]  R. Anwyl,et al.  Use-Dependent Effects of Amyloidogenic Fragments of β-Amyloid Precursor Protein on Synaptic Plasticity in Rat Hippocampus In Vivo , 2001, The Journal of Neuroscience.

[117]  S. Prusiner,et al.  Transgenic models of prion disease. , 2000, Archives of virology. Supplementum.

[118]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[119]  J. Trojanowski,et al.  The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging , 1999, Experimental Neurology.

[120]  L. Lue,et al.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.

[121]  C. Haass.  Biology of Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[122]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[123]  W. K. Cullen,et al.  Block of LTP in rat hippocampus in vivo by β‐amyloid precursor protein fragments , 1997 .

[124]  W. K. Cullen,et al.  β‐Amyloid produces a delayed NMDA receptor‐ dependent reduction in synaptic transmission in rat hippocampus , 1996, Neuroreport.

[125]  H. Edelberg,et al.  The biology of Alzheimer's disease , 1996, Mechanisms of Ageing and Development.

[126]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[127]  P. Lansbury,et al.  The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.

[128]  J. Overmier,et al.  Effects of an exogenous β-amyloid peptide on retention for spatial learning , 1994 .

[129]  J. Overmier,et al.  Effects of an exogenous beta-amyloid peptide on retention for spatial learning. , 1994, Behavioral and neural biology.

[130]  G. Forloni,et al.  Neurotoxicity of a prion protein fragment , 1993, Nature.

[131]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[132]  J. Morley,et al.  Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[133]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[134]  T. Crow,et al.  CNS amyloid proteins in neurodegenerative diseases , 1988, Neurology.

[135]  T. Teyler.  Long-term potentiation and memory. , 1987, International journal of neurology.